Vineet N. KewalRamani, Ph.D.Link to KewalRamani home pageLink to KewalRamani research pageLink to KewalRamani publications pageLink to KewalRamani staff page
... Skip navigation links
Link to home page of HIV Drug Resistance Program website
Link to Mission, HIV Drug Resistance Program, National Cancer Institute
Link to Symposium on Antiviral Drug Resistance - external website
Link to News & Events, HIV Drug Resistance Program, National Cancer Institute
Link to Research Team, HIV Drug Resistance Program, National Cancer Institute
Link to Clinical Trials, HIV Drug Resistance Program, National Cancer Institute
Link to Recruitment, HIV Drug Resistance Program, National Cancer Institute
Link to Resources, HIV Drug Resistance Program, National Cancer Institute
Link to Related Sites, HIV Drug Resistance Program, National Cancer Institute
Link to Staff Directory, HIV Drug Resistance Program, National Cancer Institute

Link to National Cancer Institute - external website
Link to National Cancer Institute at Frederick - external website
...

Photo of Vineet N. KewalRamani

Head, Model Development Section

HIV Drug Resistance Program
National Cancer Institute
NCI-Frederick, P.O. Box B, Building 535
Frederick, MD 21702-1201
Phone: 301-846-1249
Fax: 301-846-6777
E-mail: vineet@ncifcrf.gov
E-mail: vineet@mac.com


Dr. Vineet N. KewalRamani first developed an interest in retroviruses as an undergraduate in the lab of Antonito T. Panganiban at the McArdle Cancer Center, University of Wisconsin at Madison.  After choosing to pursue molecular biology as a career, he next went to the University of Washington in Seattle and did his graduate work studying HIV molecular virology in the lab of Michael Emerman at the Fred Hutchinson Cancer Research Center.  After completing his Ph.D. in 1996, he moved to New York to join the lab of Dan R. Littman to better understand HIV infection within an immunological context.  While working in the Littman lab, Dr. KewalRamani joined in an effort to develop a murine model for HIV replication using transgenic technologies.  These studies provided the foundation for his lab's current studies of understanding the blocks to HIV replication in murine cells, identifying human cell cofactors involved in HIV replication, and translating these basic science findings to develop better cell culture and animal models for HIV infection studies.



Last modified: 15 December 2008

...



HIV DRP Home
Mission | Symposium | News & Events | Research Team | Clinical Trials | Recruitment | Resources
Related Sites | Staff Directory | NCI Home | NCI-Frederick | Site Map | Disclaimers & Policies | Contact Us

Accessibility | Viewing Files

National Cancer Institute logo     Health and Human Services logo National Institutes of Health logo Logo of USA.gov official web portal